Brought to you by:
SVS Vascular Health Step Challenge asks surgeons to walk the walk
Most American adults take an average of 5,000 steps per day. In fact, this simple act—getting out and moving—can be the key to prevention and treatment of many chronic diseases of the cardiovascular system. The Society for Vascular Surgery (SVS)…
Black adults treated for common arterial disease are at greater risk of amputation, death than white adults, researchers show
About 6.5 million Americans over the age of 40 suffer from peripheral arterial disease (PAD). In the U.S., Black adults in their 50s are at least twice as likely to suffer from PAD as their white counterparts, a disparity that…
Female sex is associated with additional treatments following surgery for intermittent claudication, study shows
A new U.S. study has found that female sex is associated with more reinterventions after surgical treatment for intermittent claudication. Additionally, guideline-directed medical therapy, including aspirin and statin use, was used less frequently among female compared with male patients in…
Cordis announces start of enrollment in RADIANCY clinical study in Europe
Cordis has announced the start of the European RADIANCY premarket clinical study of a stent system designed for radial access in the treatment of peripheral artery disease (PAD). RADIANCY is a prospective, multicenter, single-arm study to assess the safety and…
PAD: Ra Medical Systems receives FDA 510(k) clearance for the Dabra 2.0 catheter
Ra Medical Systems has announced receipt of Food and Drug Administration (FDA) 510(k) clearance for the company’s Dabra 2.0 catheter as part of the Dabra excimer laser system for the treatment of peripheral arterial disease (PAD). A company press release…
SVS creates limb salvage-focused Frank J. Veith Lectureship
Next year’s Vascular Annual Meeting (VAM) will include a new named lecture: the Frank J. Veith Lecture, named in honor of former Society for Vascular Surgery (SVS) President Frank Veith, MD. Immediate Past President Ali AbuRahma, MD, announced the new…
New project will develop nanoparticles with imaging and medicine-delivery capabilities to better treat PAD
A University of Texas at Arlington bioengineer is leading a project to develop biodegradable nanomaterials that will take pictures and deliver medicine to combat peripheral arterial disease (PAD), the university announced in a press release. Kytai Nguyen, a UTA bioengineering…
First results from BEST-CLI poised to reveal ‘very low’ quality of life for patients entering the trial, especially women
An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual Meeting (VAM) demonstrated patient-specific variables such as self-reported female gender, current smoking, impaired mobility and opioid…
Study demonstrates feasibility, effectiveness of at-home exercise therapy plus cognitive behavior therapy for IC
A mobile phone-administered, home-based exercise therapy program for patients with intermittent claudication (IC) incorporating cognitive behavior therapy (CBT) was found to be feasible, with 78% of participants completing the whole course, the 2022 Vascular Annual Meeting (VAM) heard. The findings…
Researchers report higher three-year amputation and reintervention rates in Black and Hispanic CLTI patients
In a study of over 7,000 chronic limb-threatening ischemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention rates; survival, however, was higher among Black patients and similar between Hispanic and White patients. Aderike…